ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 72 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,371,000 | -56.1% | 135,000 | -37.0% | 0.04% | -58.4% |
| Q1 2021 | $5,400,000 | +248.6% | 214,300 | -10.5% | 0.10% | +206.1% |
| Q4 2020 | $1,549,000 | +119.7% | 239,400 | -12.8% | 0.03% | +106.2% |
| Q3 2020 | $705,000 | +58.4% | 274,400 | 0.0% | 0.02% | +77.8% |
| Q2 2020 | $445,000 | +169.7% | 274,400 | +213.6% | 0.01% | +350.0% |
| Q4 2019 | $165,000 | +73.7% | 87,500 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $95,000 | -50.5% | 87,500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $192,000 | – | 87,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |